Oxidative processes in clinical conditions
Oxidative processes are a fundamental component of normal cellular metabolism. Under pathological conditions, excessive generation of free radicals and reactive oxygen species (ROS) can exceed protective capacity, resulting in oxidative stress and tissue injury.
In oncology, surgical interventions are frequently extensive and traumatic, and may be combined with chemotherapy and radiation therapy. These treatments can contribute to tumor cell damage through free-radical mechanisms while simultaneously exposing healthy tissues to oxidative burden.
Surgical trauma, anesthesia, massive blood loss, and ischemia–reperfusion phenomena can further amplify oxidative stress. In severe cases, this imbalance may contribute to endogenous intoxication and the development of multiple organ dysfunction syndrome (MODS) in high-risk patients.
Anesthesia and oxidative imbalance
Many anesthetic agents exert their effects by altering the physicochemical properties of biological membranes. Because membranes are particularly susceptible to lipid peroxidation, general anesthesia has been described as capable of both directly and indirectly activating free-radical processes—placing additional demand on endogenous antioxidant defenses.
Antioxidant defense system of the body
The antioxidant system is a multicomponent network of enzymatic, protein, and low-molecular-weight compounds that regulates the formation and neutralization of free radicals and peroxide intermediates.
Endogenous antioxidants are commonly classified into primary, secondary, tertiary, and quaternary groups based on their functional role and site of action within antiradical processes. Together, these components form a dynamic “buffer system” that helps maintain redox homeostasis under physiological conditions.
Depletion or failure of antioxidant capacity can lead to uncontrolled oxidation of lipids, proteins, and nucleic acids, resulting in membrane injury, enzyme inactivation, disrupted intercellular signaling, and impaired immune responsiveness.
Oxidative stress in cancer
Persistent oxidative stress is considered a relevant mechanism in both the initiation and progression of malignant neoplasms. Free radicals can interact with genetic material, contributing to DNA damage, genomic instability, and lipid peroxidation.
Clinical observations often report elevated levels of lipid peroxidation products (for example, malondialdehyde) in patients with cancers of the gastrointestinal tract, liver, pancreas, respiratory system, and gynecological organs. The intensity of oxidative processes is frequently discussed in relation to tumor burden and disease progression.
Excessive radical formation is also associated with cancer-related endotoxicosis, metabolic dysregulation, immune suppression, and reduced nonspecific resistance.
Clinical relevance of antioxidant research
Over recent decades, significant attention has been devoted to assessing oxidative–antioxidant balance across diseases. Altered antioxidant status is recognized as a common biochemical feature in numerous pathological conditions.
Evaluation of antioxidant defense components is increasingly discussed as an indirect marker of nonspecific resistance and detoxification capacity. This has contributed to interest in endogenous antioxidants such as ceruloplasmin and lactoferrin as potential modulators of oxidative and inflammatory responses.
Summary
Oxidative stress is a central mechanism discussed in cancer, surgery-related complications, systemic inflammation, and endotoxemia. The balance between prooxidant and antioxidant processes influences tissue integrity, immune competence, and adaptive capacity.
Understanding these mechanisms provides a medical framework for investigating antioxidant strategies and biologically active molecules within broader therapeutic and supportive care concepts.